Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Janne C. Mewes"'
Autor:
Joost Verbeek, Vera Atema, Marc van Beurden, Valesca P. Retèl, Hester S. A. Oldenburg, Myra S. Hunter, Neil K. Aaronson, Marieke van Leeuwen, Wim H. van Harten, Janne C. Mewes
Publikováno v:
Breast Cancer Research and Treatment
Breast cancer research and treatment, 178(3), 573-585. Springer
Breast Cancer Research and Treatment, 178(3), 573-585. Springer New York
Breast cancer research and treatment, 178(3), 573-585. Springer
Breast Cancer Research and Treatment, 178(3), 573-585. Springer New York
PURPOSE: Internet-based cognitive behavioral therapy (iCBT), with and without therapist support, is effective in reducing treatment-induced menopausal symptoms and perceived impact of hot flushes and night sweats (HF/NS) in breast cancer survivors. T
Autor:
Wim H. van Harten, Janne C. Mewes, Marnix H Geukes Foppen, Lotte Maria Gertruda Steuten, Valesca P. Retèl, John B. A. G. Haanen, Melanie Lindenberg
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
BMC cancer, 18(1):895. BioMed Central
BMC cancer, 18(1):895. BioMed Central
Background An emerging immunotherapy is infusion of tumor infiltrating Lymphocytes (TIL), with objective response rates of around 50% versus 19% for ipilimumab. As an Advanced Therapeutic Medicinal Products (ATMP), TIL is highly personalized and comp
Autor:
Marc van Beurden, Myra S. Hunter, Saskia F. A. Duijts, Jacobien M. Kieffer, Janne C. Mewes, Neil K. Aaronson, Hester S. A. Oldenburg, Willem H. van Harten, Martijn M. Stuiver, Lotte Maria Gertruda Steuten
Publikováno v:
Journal of cancer survivorship, 9(1), 126-135. Springer
Journal of Cancer Survivorship, 9(1), 126-135. Springer New York
Mewes, J C, Steuten, L M G, Duijts, S F A, Oldenburg, H S A, van Beurden, M, Stuiver, M M, Hunter, M S, Kieffer, J M, van Harten, W H & Aaronson, N K 2015, ' Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients ', Journal of Cancer Survivorship, vol. 9, no. 1, pp. 126-135 . https://doi.org/10.1007/s11764-014-0396-9
Journal of cancer survivorship, 9(1), 126-135. Springer New York
Journal of Cancer Survivorship, 9(1), 126-135. Springer New York
Mewes, J C, Steuten, L M G, Duijts, S F A, Oldenburg, H S A, van Beurden, M, Stuiver, M M, Hunter, M S, Kieffer, J M, van Harten, W H & Aaronson, N K 2015, ' Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients ', Journal of Cancer Survivorship, vol. 9, no. 1, pp. 126-135 . https://doi.org/10.1007/s11764-014-0396-9
Journal of cancer survivorship, 9(1), 126-135. Springer New York
Objectives: Many breast cancer patients suffer from (severe) menopausal symptoms after an early onset of menopause caused by cancer treatment. The standard treatment for these complaints is hormone replacement therapy, which, however, is contraindica
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
Objectives: Metastatic melanoma has a poor prognosis with 10 year survival being 50% and expected survival rates of 25%-42% versus 45% (1yr) and 23,5% (2yr) for Ipilimumab. TIL is highly personalized, however complex and requests substantial upfront
Autor:
Angela G. E. M. de Boer, Iris F. Groeneveld, Wim H. van Harten, Monique H. W. Frings-Dresen, Lotte Maria Gertruda Steuten, Maarten Joost IJzerman, Janne C. Mewes
Publikováno v:
BMC Cancer
BMC cancer, 15(1). BioMed Central
BMC cancer, 15:899. BioMed Central Ltd.
BMC cancer, 15(1). BioMed Central
BMC cancer, 15:899. BioMed Central Ltd.
Background: Return-to-work (RTW)-interventions support cancer survivors in resuming work, but come at additional healthcare costs. The objective of this study was to assess the budget impact of a RTW-intervention, consisting of counselling sessions w
Publikováno v:
Journal of clinical oncology, 33(15, suppl.). American Society of Clinical Oncology
Background: Metastatic melanoma has a poor prognosis with 10 year survival being < 5%. Standard therapy in the Netherlands is the effective but costly Ipilimumab. An emerging 1st line immunotherapy is Tumor Infiltrating Lymphocytes (TIL)-treatment, w
Publikováno v:
Oncologist, 17, 1-14. AlphaMed Press
Introduction. Many cancer survivors suffer from a combination of disease- and treatment-related morbidities and complaints after primary treatment. There is a growing evidence base for the effectiveness of monodimensional rehabilitation interventions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e8e7ce04f84c3b6bf43ea9124dc6e5
https://research.utwente.nl/en/publications/effectiveness-of-multidimensional-cancer-survivor-rehabilitation-and-costeffectiveness-of-cancer-rehabilitation-in-general-a-systematic-review(62bd25dc-f898-412e-b071-988bb86c80d6).html
https://research.utwente.nl/en/publications/effectiveness-of-multidimensional-cancer-survivor-rehabilitation-and-costeffectiveness-of-cancer-rehabilitation-in-general-a-systematic-review(62bd25dc-f898-412e-b071-988bb86c80d6).html